Skip to main content
Year archive

ANTEROGEN CO., LTD. — 2022 filings

All 36 regulatory filings released by ANTEROGEN CO., LTD. (065660) in 2022, sourced directly from the official regulator.

36 Filings
2022 Period
2022 filings (36)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2022-12-16 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-08-12 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-07-22 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-06-29 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-13 Korean
[기재정정]분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-16 Korean
대표이사변경
Board/Management Information
2022-03-16 Korean
전환가액의조정(제5회차)
Capital/Financing Update
2022-03-08 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제5회차)
Capital/Financing Update
2022-03-08 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-08 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-03-08 Korean
사업보고서 (2021.12)
Audit Report / Information FY 2021
2022-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-02 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2022-02-28 Korean
합병등종료보고서(합병)
M&A Activity
2022-02-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-02-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-02-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-02-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-02-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-02-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-02-22 Korean
불성실공시법인지정(공시불이행)
Regulatory Filings
2022-02-17 Korean
주권매매거래정지(불성실공시법인 지정)
Delisting Announcement
2022-02-17 Korean
주주총회소집결의
AGM Information
2022-02-11 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity
2022-02-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-02-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-02-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-01-28 Korean
불성실공시법인지정예고(공시불이행)
Regulatory Filings
2022-01-26 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-01-24 Korean
투자판단관련주요경영사항(Wagner grade 1 및 2 당뇨병성 족부궤양 환자를 대상으로 한 ALLO-ASC-DFU 국내 임상 3상 분석 결과)
Regulatory Filings
2022-01-21 Korean
기타경영사항(자율공시)(씨에스케이 주식회사와의 소규모 합병 승인 이사회 결의(주주총회 갈음) 결과 보고)
M&A Activity
2022-01-17 Korean